In this Coronavirus Special, Wes interviews Dr. Amesh Adalja of Johns Hopkins University Center for Health Security about COVID-19. Dr. Adalja’s work is focused on emerging infectious diseases, pandemic preparedness, and biosecurity. We dig into the mortality rate of this virus and the data that the world is currently basing this very important statistic around. Dr. Adalja gives his reasoning on why the mortality rate will likely drop from the currently reported 3% down to possibly 0.5%. He also gives his perspective on South Korea’s healthcare system and when he expects to see a vaccine available to the public. We cover these topics and more! Be sure to listen as we try to demystify COVID-19.
This information is provided to you as a resource for educational purposes only and should not be considered investment advice or recommendation or an endorsement of any particular security. Investing involves risk, including the possible loss of principal. There is no guarantee offered that investment return, yield, or performance will be achieved. There will be periods of performance fluctuations, including periods of negative returns. Past performance is not indicative of future results when considering any investment vehicle. The mention of any specific security should not be inferred as having been successful or responsible for any client achieving their investment goals. Additionally, the mention of any specific security is not to infer investment success of the security or of any portfolio. Past performance is not indicative of future results. A reader may request a list of all recommendations made by Capital Investment Advisors within the immediately preceding period of one year upon written request to Capital Investment Advisors. It is not known whether any client holding the mentioned securities have achieved their investment goals or experienced appreciation of their portfolio. This information is being presented without consideration of the investment objectives, risk tolerance, or financial circumstances of any specific investor and might not be suitable for all investors. This information is not intended to, and should not, form a primary basis for any investment decision that you may make. Always consult your own legal, tax, or investment advisor before making any investment/tax/estate/financial planning considerations or decisions.